Cargando…
Antiviral Treatment of Coronavirus Disease-2019 Pneumonia
Direct acting antivirals and monoclonal antibodies reduce morbidity and mortality associated with severe acute respiratory syndrome coronavirus 2 infection. Persons at higher risk for disease progression and hospitalized patients with coronavirus disease-2019 (COVID-19) benefit most from available t...
Autores principales: | Radcliffe, Christopher, Malinis, Maricar, Azar, Marwan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701636/ https://www.ncbi.nlm.nih.gov/pubmed/37085220 http://dx.doi.org/10.1016/j.ccm.2022.11.008 |
Ejemplares similares
-
Nocardiosis and elevated beta-d-glucan in solid organ transplant recipients
por: Ringer, Matthew, et al.
Publicado: (2021) -
Real-world assessment of the clinical utility of whole body (18)F-FDG PET/CT in the diagnosis of infection
por: Medvedeva, Natalia, et al.
Publicado: (2022) -
Diagnostic Testing of COVID-19 in Solid Organ Transplantation: Current Clinical Application and Future Strategies
por: Trubin, Paul A., et al.
Publicado: (2020) -
1388. Characteristics of Non-Tuberculous Mycobacterial Infections in Hematopoietic Stem-Cell Transplant Patients
por: Gleeson, Shana E, et al.
Publicado: (2019) -
2566. Diagnosis of Pneumocystis jiroveci Pneumonia in HIV-Negative Immunocompromised Patients: Is the Gomori-Methenamine Silver Stain of Bronchoalveolar Lavage Fluid the Gold Standard or Sub-Standard?
por: Slotkin, Rebecca, et al.
Publicado: (2018)